Integrative Multiomics Analysis Reveals the Ameliorative Effects of Astragalus membranaceus Extract on Metabolic Dysfunction-Associated Steatotic Liver Disease
Molecules · 28.03.2026 · 31 (7) · 1120
DOI: 10.3390/molecules31071120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 28.03.2026. Verfasst von Jiayi An und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Biological Sciences and Technology, Yili Normal University, Yining 835000, China. Hauptthemen laut MEDLINE: Plant Extracts, Astragalus propinquus, Non-alcoholic Fatty Liver Disease, Fatty Liver. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Key Scientific Research Programs of the Henan Education Department, the Start - up Fund for Doctoral Research of Yili Normal University, Henan Education Department https://ror.org/00xvf9d29.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health burden, yet effective therapeutic options remain limited. This study investigated the protective mechanisms of Astragalus membranous extract (AM) against high-fat diet (HFD)-induced MAFLD in mice using an integrated strategy combining network pharmacology, hepatic metabolomics, and 16S rRNA sequencing. UPLC–Q-Orbitrap–MS/MS identified 37 major constituents in AM, mainly phenolic acids and flavonoids. Iristectorin A, isorhamnetin, ononin, and rhamnocitrin were identified as key candidate compounds due to their relatively high abundance and confirmation as absorbed constituents in vivo. Network pharmacology and molecular docking indicated favorable interactions with hub targets (TNF, EGFR, and AKT1; binding energies < −5.0 kcal/mol) and highlighted the involvement of the AGE–RAGE signaling pathway and inflammation- and lipid metabolism-related processes. In vivo, AM significantly attenuated HFD-induced weight gain, decreased serum ALT and AST levels, and reduced hepatic lipid deposition. AM also alleviated oxidative stress by lowering malondialdehyde (MDA) and increasing superoxide dismutase (SOD) activity, while suppressing hepatic IL-1β and IL-6. Moreover, AM improved gut microbial homeostasis by restoring α-diversity and enriching beneficial genera, including Akkermansia and Bacteroides. Hepatic metabolomics further showed that AM partially normalized lipid metabolic disturbances, particularly glycerophospholipid and sphingolipid metabolism. Collectively, these results suggest that AM mitigates MASLD via a multi-component, multi-target mechanism, potentially through modulation of AGE–RAGE-associated inflammatory signaling and the gut–liver axis, supporting its development as a functional food-derived candidate for metabolic liver disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biological Sciences and Technology, Yili Normal University, Yining 835000, China.
- College of Life Sciences, Henan Normal University, Xinxiang 453007, China.
Förderung
- the Key Scientific Research Programs of the Henan Education Department
- the Start - up Fund for Doctoral Research of Yili Normal University
- Henan Education Department https://ror.org/00xvf9d29
- Yili Normal University https://ror.org/019htgm96
Zitieren
APA
An, J., Li, Y., Zhang, Z., Chang, Y., & Xiao, G. (2026). Integrative Multiomics Analysis Reveals the Ameliorative Effects of Astragalus membranaceus Extract on Metabolic Dysfunction-Associated Steatotic Liver Disease. Molecules, 31(7), 1120. https://doi.org/10.3390/molecules31071120
Vancouver
An J, Li Y, Zhang Z, Chang Y, Xiao G. Integrative Multiomics Analysis Reveals the Ameliorative Effects of Astragalus membranaceus Extract on Metabolic Dysfunction-Associated Steatotic Liver Disease. Molecules. 2026;31(7):1120. doi:10.3390/molecules31071120
BibTeX
@article{An2026,
author = {An, Jiayi and Li, Yi and Zhang, Zunhan and Chang, Yaru and Xiao, Guanxiu},
title = {Integrative Multiomics Analysis Reveals the Ameliorative Effects of Astragalus membranaceus Extract on Metabolic Dysfunction-Associated Steatotic Liver Disease},
journal = {Molecules},
year = {2026},
volume = {31},
number = {7},
pages = {1120},
doi = {10.3390/molecules31071120}
}
EUVIMED